A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy

被引:124
作者
Ding, Yang [1 ]
Wang, Wei [1 ]
Feng, Meiqing [2 ]
Wang, Yu [3 ]
Zhou, Jianping [1 ]
Ding, Xuefang [1 ]
Zhou, Xin [1 ]
Liu, Congyan [1 ]
Wang, Ruoning [1 ]
Zhang, Qiang [4 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] Fu Dan Univ, Sch Pharm, Shanghai 201203, Peoples R China
[3] Nanjing Med Univ, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China
[4] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
Reconstituted high density lipoprotein; Apolipoprotein A-I; Targeted cholesterol-conjugated siRNA delivery; Pokemon; Tumor gene therapy; HIGH-DENSITY-LIPOPROTEIN; ANTI-HBV ACTIVITY; IN-VIVO DELIVERY; CELL LUNG-CANCER; SR-BI; REPRESSES TRANSCRIPTION; SCAVENGER RECEPTOR; RNA INTERFERENCE; BREAST-CANCER; LIVER-CELLS;
D O I
10.1016/j.biomaterials.2012.08.057
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
RNA interference holds tremendous potential as a therapeutic approach of malignant tumors. However, safe and efficient nanovectors are extremely lack for systemic delivery of small interfering RNA (siRNA). The study aimed to develop a biomimetic nanovector, reconstituted high density lipoprotein (rHDL), mediating targeted cholesterol-conjugated siRNA (Chol-siRNA) delivery for Pokemon gene silencing therapy. Chol-siRNA-loaded rHDL nanoparticles (rHDL/Chol-siRNA complexes) were prepared using thin-film dispersion method and their characteristics were investigated in detail. RHDL/Chol-siRNA complexes at the optimal volume ratio (lipid: Chol-siRNA) exhibited high Chol-siRNA-loading efficiency (similar to 99%), desirable nanoparticle size and excellent stability in serum. In addition, by analyzing Chol-siRNA release profile, rHDL/Chol-siRNA complexes displayed sustained-release characteristic and storage stability. Observations from FACS and confocal microscopic analyses revealed that rHDL-mediated carboxyfluorescein tagged Chol-siRNA (FAM-Chol-siRNA) transfection resulted in highly efficient uptake and specific cytoplasmic delivery of FAM-Chol-siRNA into human hepatocellular carcinoma cell line HepG2 via HDL-receptor mediated mechanism. In vitro cytotoxicity, apoptosis and Western-blot analyses revealed significant cellular growth inhibition and decrease of Pokemon and Bcl-2 protein expression in HepG2 cells treated with Chol-siRNA-Pokemon-loaded rHDL nanoparticles (rHDL/Chol-siRNA-Pokemon complexes), respectively. In in vivo studies, the near-infrared (NIR) dye Cy5 labeled Chol-siRNA-loaded rHDL nanoparticles (rHDL/Cy5-Chol-siRNA complexes) obviously accumulated in tumor of nude mice after i.v. administration as compared with Cy5-Chol-siRNA-loaded lipoplexes (Lipos/Cy5-Chol-siRNA complexes). Morover, rHDL/Chol-siRNA-Pokemon complexes demonstrated great tumor growth inhibition and significant decrease of Pokemon and Bcl-2 protein expression in vivo. These results suggested that rHDL should be an ideal non-viral tumor-targeting vector for Chol-siRNA transfer, and rHDL-mediated Chol-siRNA-Pokemon delivery might be a promising new strategy for gene therapy in hepatocellular carcinoma. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8893 / 8905
页数:13
相关论文
共 43 条
[1]   Regulation of the p14ARF-Mdm2-p53 pathway: An overview in breast cancer [J].
Agrawal, Anshu ;
Yang, Jianhui ;
Murphy, Richard F. ;
Agrawal, Devendra K. .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2006, 81 (02) :115-122
[2]   Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer [J].
Apostolopoulou, K. ;
Pateras, I. S. ;
Evangelou, K. ;
Tsantoulis, P. K. ;
Liontos, M. ;
Kittas, C. ;
Tiniakos, D. G. ;
Kotsinas, A. ;
Cordon-Cardo, C. ;
Gorgoulis, V. G. .
JOURNAL OF PATHOLOGY, 2007, 213 (03) :294-302
[3]   Homing in on delivery [J].
Baker, Monya .
NATURE, 2010, 464 (7292) :1225-1230
[4]   Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells [J].
Chiu, YL ;
Ali, A ;
Chu, CY ;
Cao, H ;
Rana, TM .
CHEMISTRY & BIOLOGY, 2004, 11 (08) :1165-1175
[5]   Proto-oncogene FBI-1 Represses Transcription of p21CIP1 by Inhibition of Transcription Activation by p53 and Sp1 [J].
Choi, Won-Il ;
Jeon, Bu-Nam ;
Yun, Chae-Ok ;
Kim, Pyung-Hwan ;
Kim, Sung-Eun ;
Choi, Kang-Yell ;
Kim, Se Hoon ;
Hur, Man-Wook .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (19) :12633-12644
[6]  
Collet X, 1999, J LIPID RES, V40, P1185
[7]   Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids [J].
Connelly, MA ;
Williams, DL .
CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (03) :287-295
[8]   SR-BI and HDL cholesteryl ester metabolism [J].
Connelly, MA ;
Williams, DL .
ENDOCRINE RESEARCH, 2004, 30 (04) :697-703
[9]   Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells [J].
Cui, Jiajun ;
Meng, Xianfeng ;
Gao, Xudong ;
Tan, Guangxuan .
MOLECULAR BIOLOGY REPORTS, 2010, 37 (03) :1627-1632
[10]   Interfering with disease: a progress report on siRNA-based therapeutics [J].
de Fougerolles, Antonin ;
Vornlocher, Hans-Peter ;
Maraganore, John ;
Lieberman, Judy .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) :443-453